Study of Octagam 10% on the Treatment of Mild to Moderate Alzheimer's Patients
This study has been completed.
Sponsor:
Octapharma
Information provided by (Responsible Party):
Octapharma
ClinicalTrials.gov Identifier:
NCT00812565
First received: November 10, 2008
Last updated: May 6, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
No publications provided by Octapharma
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):